Prelude Capital Management, LLC Bluebird Bio, Inc. Call Options Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
Call Options
2 transactions
Others Institutions Holding BLUE
# of Institutions
157Shares Held
79.1MCall Options Held
506KPut Options Held
603K-
Black Rock Inc. New York, NY15.4MShares$6.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$4.08 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$2.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$1.83 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $30.1M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...